JX11502MA capsule

· Zhejiang Jingxin Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JX11502MA capsule, covering 2024-04-10 to 2024-04-10. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia. [Phase 1, Phase 2]

See pricing